(Q38183485)

30 August 2017

title

Micro-RNAs and ovarian cancer: the state of art and perspectives of clinical research (English)

1 reference

30 August 2017

1 reference

1

1 reference

30 August 2017

author name string

Claudia Sergiampietri

series ordinal

2

1 reference

30 August 2017

Nora Lanfredini

series ordinal

3

1 reference

30 August 2017

Ilaria Guiggi

series ordinal

4

1 reference

30 August 2017

publication date

30 January 2014

1 reference

Gynecological Endocrinology

30 August 2017

published in

1 reference

30 August 2017

volume

30

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

266-271

1 reference

microRNAs: Master Regulators as Potential Therapeutics in Cancer

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNAs in stress signaling and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Processing of intronic microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Biogenesis of small RNAs in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Roles of small RNAs in tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

miR221/222 in cancer: their role in tumor progression and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

A microRNA component of the p53 tumour suppressor network

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA expression and identification of putative miRNA targets in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNAs in ovarian cancer biology and therapy resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MiR-200c and HuR in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Polo-like kinase 1 reaches beyond mitosis--cytokinesis, DNA damage response, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

The let-7 microRNA represses cell proliferation pathways in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Genomic DNA copy-number alterations of the let-7 family in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Dicer, Drosha, and outcomes in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Update of research on the role of EZH2 in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Identification of miRNA modulators to PARP inhibitor response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2013.871525

The Role of microRNAs in the Tumorigenesis of Ovarian Cancer

21 January 2018

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.3389/FONC.2013.00153

Identifiers

DOI

10.3109/09513590.2013.871525

1 reference

30 August 2017

1 reference